Celldex Therapeutics | CLDX - 税引前利益





税引前利益 変化する 日付
AbbVie USD 5.57B 2.9B 2026-03
Agenus USD -10.61M 263.52M 2025-12
Amgen USD 1.51B 2.41B 2025-12
Bristol-Myers Squibb USD 1.47B 1.64B 2025-12
Celldex Therapeutics USD -81.32M 14.27M 2025-12
Glaxosmithkline GBP 2.46B 569M 2025-09
Nektar Therapeutics USD -34.7M 2.35M 2025-12
Pfizer USD 5.18B 6.82B 2026-03
Rigel Pharmaceuticals USD -1.03M 7.22M 2024-06
Roche Holding CHF 4.79B 3.01B 2025-06